Article

Re: Schaub et al.: Intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy: results from a randomized clinical trial (Ophthalmology. 2022;129:1129–1141)

Ophthalmology
DOI: 10.1016/j.ophtha.2023.02.022
2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

van Overdam, K. A., & Sebag, J. (2023, June 1). Re: Schaub et al.: Intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy: results from a randomized clinical trial (Ophthalmology. 2022;129:1129–1141). Ophthalmology. Elsevier Inc. https://doi.org/10.1016/j.ophtha.2023.02.022

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free